PNC Financial Services Group’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107 Buy
27
+22
+440% +$60 ﹤0.01% 5141
2026
Q1
$7 Buy
+5
New +$10 ﹤0.01% 5155
2025
Q4
– Sell
-35
Closed -$235 – 5306
2025
Q3
$235 Hold
35
– – ﹤0.01% 4922
2025
Q2
$206 Hold
35
– – ﹤0.01% 4795
2025
Q1
$294 Hold
35
– – ﹤0.01% 4730
2024
Q4
$260 Sell
35
-400
-92% -$2.68K ﹤0.01% 4620
2024
Q3
$2.52K Buy
+435
New +$2.79K ﹤0.01% 4233
2023
Q3
– Sell
-191
Closed -$4.89K – 4754
2023
Q2
$4.89K Buy
+191
New +$4.93K ﹤0.01% 4119

Other funds holding TMCI

PNC Financial Services Group's TMCI Position: Q2 2026 in Review

PNC Financial Services Group increased its Treace Medical Concepts (TMCI) stake by 440% in Q2 2026, buying an estimated $60 and bringing the position to 27 shares worth $107. The position accounts for ﹤0.01% of the portfolio, ranked #5141.

PNC Financial Services Group first reported a position in TMCI in Q2 2023 and has held it in 8 quarters since. The position peaked at $4.89K in Q2 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • PNC Financial Services Group held 27 shares of Treace Medical Concepts worth $107 as of Q2 2026.
  • PNC Financial Services Group bought 22 Treace Medical Concepts shares in Q2 2026, an estimated $60.
  • Treace Medical Concepts made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5141 holding.
  • PNC Financial Services Group first reported a position in Treace Medical Concepts in Q2 2023 and has held it in 8 quarters since.
  • PNC Financial Services Group's Treace Medical Concepts position peaked at $4.89K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.